Literature DB >> 3165691

Nature of distamycin A-inducible fragile sites.

T Hori1, E Takahashi, M Murata.   

Abstract

Five rare distamycin A-inducible fragile sites have been identified on human chromosomes: fra(8)(q24.1), fra(11)(p15.1), fra(16)(p12.1), fra(16)(q22), and fra(17)(p12). All of these fragile sites are located at the junction of Giemsa-positive (G) and negative (R) bands and their expression can be induced by a variety of AT specific DNA ligands. Analysis of family data indicate that the distamycin A-inducible fragile sites segregate as a simple codominant trait with complete penetrance, and probands receive these fragile site genes equally from mothers and fathers. Based on current knowledge of chromosome instability, the nature of distamycin A-inducible fragile sites is discussed. Distamycin A-inducible fragile sites appear to be unique chromosomal regions particularly susceptible to fragility under certain stress conditions. They may also be hot spots for recombination, gene amplification, and integration of foreign genomes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3165691     DOI: 10.1016/0165-4608(88)90258-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Induction of distamycin A-inducible rare fragile sites and increased sister chromatid exchanges at the fragile site.

Authors:  H Tsuji; A Hitomi; E Takahashi; M Murata; T Ikeuchi; K Yamamoto; S Tsuji; T Hori
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

2.  Human papillomavirus episome stability is reduced by aphidicolin and controlled by DNA damage response pathways.

Authors:  Terri G Edwards; Michael J Helmus; Kevin Koeller; James K Bashkin; Chris Fisher
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

3.  Chromosomal insertion and amplification of human papillomavirus 16 DNA sequences in a cell line of argyrophil small cell carcinoma of the uterine cervix.

Authors:  T Hori; H Ichimura; M Minamihisamatsu; E Takahashi; M Yamauchi; Y Hama; O Kurimura; M Yamasaki; T Kurimura
Journal:  Jpn J Cancer Res       Date:  1991-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.